1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 What Is This Report About? 4
2.2 Lithotripters Market Segmentation 4
2.3 Definitions of Markets Covered in the Report 5
3 Lithotripters Market, France 6
3.1 Lithotripters Market, France, Revenue ($m), 2009-2016 6
3.2 Lithotripters Market, France, Revenue ($m), 2016-2023 8
3.3 Lithotripters Market, France, Volume (Units), 2009-2016 10
3.4 Lithotripters Market, France, Volume (Units), 2016-2023 12
3.5 Lithotripters Market, France, Average Price ($), 2009-2023 14
3.6 Lithotripters Market, France, Distribution Share by Revenue ($m), 2015-2016 15
3.7 Lithotripters Market, France, Company Share by Revenue ($m), 2016 16
4 Overview of Key Companies in France, Lithotripters Market 18
4.1 Dornier MedTech GmbH 18
4.1.1 Company Overview 18
4.2 Siemens Healthcare GmbH 18
4.2.1 Company Overview 18
4.3 EDAP TMS SA 18
4.3.1 Company Overview 18
4.4 Storz Medical AG 18
4.4.1 Company Overview 18
4.5 Electro Medical Systems SA 19
4.5.1 Company Overview 19
5 Lithotripters Market Pipeline Products 20
6 Recent Developments 21
6.1 Corporate Communications 21
6.1.1 Apr 12, 2017: Sanofi appoints Nikhilesh Kalra to lead Consumer Healthcare business for India and South Asia 21
6.1.2 Apr 11, 2017: Sanofi Announces Pre-quarterly Results Communication 21
6.1.3 Apr 05, 2017: Sanofi Appoints Bill Sibold Executive Vice President Sanofi Genzyme and Member of the Executive Committee 22
6.1.4 Mar 06, 2017: EDAP Appoints Vice-President of Global Medical, Regulatory and Quality Affairs in the US 22
6.1.5 Mar 02, 2017: Sanofi's Board of Directors Proposes Appointment of Melanie Lee, PhD and Bernard Charles as New Independent Directors 23
6.1.6 Feb 01, 2017: Sanofi Appoints Hugo Fry as General Manager UK 24
6.1.7 Jan 30, 2017: Sanofi Appoints Kathleen Tregoning to Executive Committee and Executive Vice President, External Affairs 24
6.1.8 Sep 30, 2016: Sanofi Appoints Alan Main to Executive Committee and Executive Vice President, Consumer Healthcare 24
6.1.9 Sep 07, 2016: Sanofi Appoints New Research Head for Immunology and Inflammation 25
6.1.10 Sep 06, 2016: Sanofi Board Of Directors Provides Update 25
6.2 Financial Announcements 26
6.2.1 Jul 12, 2017: Sanofi: Pre-quarterly Results Communication 26
6.2.2 May 17, 2017: EDAP TMS SA Reports First Quarter 2017 Results 27
6.2.3 Apr 28, 2017: Sanofi Delivers Robust Q1 2017 Financial Results 27
6.2.4 Apr 03, 2017: EDAP Achieves 63% Growth in HIFU Revenue in 2016 32
6.2.5 Feb 23, 2017: EDAP Announces Preliminary Unaudited Full Year 2016 Revenue 33
6.2.6 Feb 08, 2017: Sanofi Delivers 2016 Sales and Business EPS Growth at CER 33
6.2.7 Nov 17, 2016: EDAP Achieves 79% Growth in HIFU Revenue for First Nine Months of 2016 39
6.2.8 Oct 28, 2016: Sanofi Announces Strong Q3 2016 Results 40
6.2.9 Aug 25, 2016: EDAP Reports 69% Growth in HIFU Revenues and Operating Profit for First Half 2016 46
7 Appendix 48
7.1 Research Methodology 49
7.1.1 Coverage 49
7.1.2 Secondary Research 49
7.1.3 Primary Research 50
7.1.4 Company Share Analysis 50
7.1.5 Distribution Share Analysis 50
7.1.6 Benchmarking 51
7.2 GlobalData Consulting 51
7.3 Contact Us 52
7.4 Disclaimer 52
Agriculture and Animal Care
Automotive, Transportation and Warehousing
Banking Financial Services and Insurance
Consumer Products and Retail
Defense and Security
Education and Recruitment
Energy and Utilities
Food, Beverage and Tobacco
Healthcare
Manufacturing and Construction
Media and Entertainment
Metal, Mining and Chemicals
Public Sector and Administration
Technology and Telecom
